Biblio Discovery — Demo Discovery Service

165 results

Showing 1–20 · 0.26 seconds · RSS

Journal

Frontiers in Hematology

Scopus

ISSN 2813-3935 · Frontiers Media S.A. · 165 articles in the index

  1. Journal Article

    Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation

    Vinny Lococo; Maire Okoniewski; Abdalla Shoaib et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Autologous hematopoietic stem cell transplantation (aHSCT) is an effective treatment for hematologic malignancies. Hyperbaric oxygen (HBO) pretreatment has demonstrated safety and feasibility, improved neutrophil engraftment, and reduced mucositis in patients undergoing aHSCT. This was a…

  2. Journal Article

    Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

    Jiaxin Wu; Hongxiang Wang

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    ObjectiveTo explore the clinical characteristics, diagnosis and treatment process of a case initially diagnosed with primary immune thrombocytopenia (ITP) and finally diagnosed as chronic myeloid-monocytic leukemia (CMML).MethodsThe clinical manifestations, laboratory tests, bone marrow morphology…

  3. Journal Article

    Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma

    Guilherme Gasparini Spiandorelo; Ahmed Alnughmush; Olivia Crum et al.

    Frontiers in Hematology, Vol. 4 · 2026 · English · DOAJ Scopus

    BackgroundAnaplastic lymphoma kinase–positive large B-cell lymphoma (ALK+ LBCL) is an exceedingly rare and aggressive subtype of B-cell non-Hodgkin lymphoma, comprising less than 1% of all LBCL cases. These tumors often exhibit resistance to standard chemoimmunotherapy and targeted approaches…

  4. Journal Article

    Daratumumab in severe Evans syndrome: a case report

    Stefan M. Hillmann; Hendrik Brockhoff; Sarah Loebel et al.

    Frontiers in Hematology, Vol. 4 · 2026 · English · DOAJ Scopus

    Evans syndrome is a rare autoimmune disorder characterized by the simultaneous or sequential occurrence of autoimmune cytopenia. The disease is chronic, relapsing, and frequently refractory to standard therapies. Typical symptoms include anemia-related fatigue, pallor, and jaundice due to hemolysis…

  5. Journal Article

    The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis

    Duygu Aydemir

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Multiple myeloma (MM) is a malignant plasma cell disorder characterized by clonal proliferation within the bone marrow, systemic organ dysfunction, and inevitable relapse due to therapeutic resistance. Despite advances in proteasome inhibitors, immunomodulatory agents, monoclonal antibodies, and…

  6. Journal Article

    Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases

    Emin Abdullayev; Markus Bieringer; Anna Ossami Saidy et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    IntroductionNephrotic syndrome caused by membranoproliferative glomerulonephritis (MPGN) related to chronic lymphocytic leukemia (CLL) is a rare condition. Due to the rarity, no standard of care has been established yet. The combination of rituximab, chlorambucil and fludarabin was described as an…

  7. Journal Article

    Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center

    Andrew A. Y. Chen; Vivian T. Yin; Paula Blanco et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    BackgroundIdiopathic plasmacytic lymphadenopathy is a newly recognized subtype of idiopathic multicentric Castleman disease (iMCD-IPL) and often mimics IgG4-related disease (IgG4-RD). We present two of the first cases of iMCD-IPL diagnosed in British Columbia, Canada. Both patients had normolipemic…

  8. Journal Article

    Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

    Gratial Theres Joseph; Sandeep Kumar Swain; Himanshu Dhanda et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    PurposeChronic Myeloid Leukemia (CML) is characterized by the BCR-ABL1 fusion gene and is effectively managed with tyrosine kinase inhibitors (TKIs). However, therapeutic resistance and the persistence of leukemic stem cells pose challenges to achieving long-term remission. Tumor Necrosis…

  9. Journal Article

    Non-neoplastic histiocytic proliferations in bone marrow: a case series of uncommon morphologic findings

    Melissa Ha; Shafagh Parsazad; Luke T. Dang et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Non-neoplastic histiocytic proliferations in the bone marrow represent a heterogeneous group of reactive processes that can pose significant diagnostic challenges for pathologists. These proliferations are typically driven by underlying conditions such as infections (e.g., mycobacterial, fungal, or…

  10. Journal Article

    Crosstalk of factors underlying bone marrow niche-mediated chemoprotection in acute myeloid leukemia

    Arunim Shah; Arun Kumar Trivedi; Chandra Prakash Chaturvedi

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of immature myeloid cells in the bone marrow. Despite advances in genomic profiling and targeted therapies, patient outcomes remain poor because of high relapse rates and the persistence of…

  11. Journal Article

    Right atrial thrombus in treatment-naive patient with an early-stage classical Hodgkin lymphoma: a case report and review of the literature

    Anna Giordano; Valentina Bodanza; Francesco Angotzi et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Patients with hematologic malignancies are at increased risk of thrombotic complications, which most commonly occur during chemotherapy or in association with central venous catheter placement. Thrombotic events detected before systemic treatment initiation are uncommon, and intracardiac thrombosis…

  12. Journal Article

    Influence of the pyruvate kinase activator mitapivat (AG-348) on RBC ATP content and export and RBC adhesivity in blood from healthy subjects and sickle cell disease patients

    Apoorva Jagadish; Youwei Chen; Hongmei Zhu et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    BackgroundSickle cell disease (SCD) represents a significant global health burden and is characterized by hemolytic anemia, vaso-occlusive crises, end-organ damage, and early mortality. Red blood cells (RBCs) depend on glycolysis due to the virtual absence of mitochondria. RBC glycolysis generates…

  13. Journal Article

    Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS

    Alexander C. Angleitner; Markus Maulhardt; Justin Hasenkamp et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    BackgroundRelapse is the main cause of treatment failure after allogeneic hematopoietic cell transplantation (allo-HCT). Therapeutic donor lymphocyte infusion (DLI) and second allo-HCT are common post-relapse options, but comparative evidence from the time of relapse is limited.MethodsWe…

  14. Journal Article

    The cells of origin of the chemotherapy-curable malignancies are highly sensitive to cytotoxic chemotherapy-mediated cell death

    Emily Proudman; Philip Savage

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    At present, the detailed mechanisms of how cytotoxic chemotherapy routinely produces cure in a limited number of malignancies whilst causing only more modest effects on the majority of cancers and healthy normal cells are uncertain. In this article, we reviewed published information regarding the…

  15. Journal Article

    Reduced-intensity versus intensive induction in high-risk acute promyelocytic leukemia: a systematic review and meta-analysis

    Mohamed M. Khamis; Nehemias Antonio Guevara Rodriguez; Ranju Kunwor

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    BackgroundHigh-risk acute promyelocytic leukemia (APL) [white blood cell (WBC) count >10 × 109/L) accounts for 20%–30% of cases with early mortality of 15%–25%. Optimal induction with reduced-intensity all-trans retinoic acid plus arsenic trioxide (ATRA+ATO) versus intensive chemotherapy remains…

  16. Journal Article

    Towards safer and more effective hemotherapy: addressing critical unmet needs in restrictive and liberal blood transfusion strategies

    Emmanuel Ifeanyi Obeagu

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Blood transfusion is still among the most commonly used life-saving procedures in contemporary medicine, but identifying the ideal transfusion threshold remains a significant clinical hurdle across various patient groups. In the last twenty years, growing evidence has moved clinical practice from…

  17. Journal Article

    Case Report: A diagnostic algorithm for pediatric cholelithiasis: recognizing underlying hemolytic anemia through a case of hereditary spherocytosis

    Marialetizia Fantasia; Martha Caterina Faraguna; Riccardo Pagani et al.

    Frontiers in Hematology, Vol. 5 · 2026 · English · DOAJ Scopus

    Pediatric cholelithiasis is increasingly encountered in clinical practice, largely driven by the rising prevalence of obesity. However, chronic hemolytic disorders remain a significant and potentially underrecognized cause, particularly when presenting with mild or compensated forms. In such cases…